Andromeda Surgical
Andromeda Surgical develops autonomous surgical robots combining anatomical mapping and surgeon oversight, initially for prostate enucleation.
$15MSeries A
ParticipantActivity from announced rounds
Cybernetix Ventures is the investor identified in Andromeda Surgical’s Series A and in its own official portfolio.
Andromeda develops autonomous surgical robots combining anatomical mapping with surgeon oversight, initially for prostate enucleation. The issuer and investor materials establish the investment relationship and the company’s initial clinical application.
Andromeda Surgical develops autonomous surgical robots combining anatomical mapping and surgeon oversight, initially for prostate enucleation.